Innovation and pipeline

Finding solutions that improve patients’ lives

We aim to deliver major therapeutic advances by treating patients with a high burden of disease, offering clear benefits for patients and sound health economics for society. Our exciting R&D pipeline includes several new drug candidates and technologies to improve patients’ lives.

At Grünenthal, there is close collaboration between all stakeholders involved in research, and each is equally important. Our networked approach to R&D means that we can interlink and supplement our own expertise with external knowledge, leading to improved outcomes.

Fueling our pipeline with innovation

Chronic Low Back Pain (cLBP): What are we Talking About?

Learn more about the confusing myriad of anatomical and genetic factors that can lead to cLBP

... Discover more

Psychosocial Factors in Profiling IBS Patients

Read our article on how relevant the neuro-visceral axis is for the expression of symptoms from which visceral pain conditions, like IBS, can originate.

... Discover more

Listening to the patient – Surveys to accurately assess disease impact

View our article on the importance of and difficulties in accurately measuring and assessing the patient experience of pain for understanding disease impact, making treatment decisions, and facilitating optimal outcomes.

... Discover more